STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-64
SponsorSunnybrook Health Sciences Centre

About this trial

Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face other barriers to good health: low income, new immigrants, single mothers, etc. For these patients, taking prescription drugs - especially chronic disease treatments that may be required lifelong - can be difficult due to high costs. Patients skip doses, delay renewing prescriptions, or simply do not fill prescriptions recommended by their doctors, because they do not have insurance to cover the costs of prescriptions. Previous research by the study team has suggested that the lack of a universal drug insurance program for working-age Canadians affects the health and well-being of low-income people with diabetes. The goal of this research is to determine the clinical and economic impact of providing drug coverage for uninsured type 2 diabetics.

Eligibility criteria

Qualifiers

clinical diagnosis of type 2 diabetes record in family physician's electronic medical record

lack of medication insurance

Disqualifiers

None

Trial design

Treatments tested in this trial

  • No-cost Medications

Treatment groups

144 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Sunnybrook Health Sciences Centre

Lead sponsor

Canadian Institutes of Health Research (CIHR)

Collaborator